Have you read these stories?

Monetisation push to start with MTNL assets sale

The asset monetisation is part of the Rs 68,000-crore revival package for loss-making telecom public sector enterprises MTNL and Bhara ...
The Economic Times
English EditionEnglish Editionहिन्दी
| 03 March, 2021, 01:26 AM IST | E-Paper


    First COVAX vaccines arrive in Cambodia from India

    Health Minister Mam Bunheng was at the airport to receive the shipment of the Oxford-AstraZeneca Covishield vaccine. Prime Minister Hun Sen will be given the first dose on Thursday.

    China will give more doses of COVID-19 vaccine to Nepal

    The gift is to support Nepal's fight against the COVID-19 pandemic, Hou Yanqi said in...

    Pfizer, Oxford vaccines reduce severe COVID-19 in elderly, study finds

    The research, posted as a pre-print and yet to be peer-reviewed, estim...

    • With just four of China's many vaccine makers able to produce at least 2.6 billion doses this year, a large part of the world's population will end up inoculated not with the fancy Western vaccines boasting headline-grabbing efficacy rates, but with China's humble, traditionally made shots.

      The new vaccine differs markedly from the two already in use in the United States. Here is how they compare.

      China's first Ad5-nCoV COVID-19 vaccine was rolled out on Friday, the state-run Global Times reported on Sunday. It is the only single-dose COVID-19 vaccine that has been given conditional approval to be rolled out in China, the report quoted last Friday's story by the state broadcaster China Central Television (CCTV).

      History tells us that the best vaccination efforts are built on collaboration and coordination. We know that the U.S. and Soviet Union working together at the height of the Cold War was instrumental in testing the oral polio vaccine. I

      Almost 2 million people aged 60 to 63 will be invited after over 64s had been covered in the previous phase and letters will start arriving from Monday explaining how they can make an appointment for the jab.

      U.S. regulators on Saturday authorized a third COVID-...

      In a rare reference to private health matters, the 94-year-old monarch backed the National Health Service (NHS) led vaccination programme in the UK during a video call earlier this week with health officials coordinating the rollout across England, Wales, Scotland and Northern Ireland.

      The limited data available suggests the vaccines will at least partly reduce transmission, and the studies to determine this with more clarity are underway. There should be more data within the next couple of months. Until then, precautionary measures like masking and distancing in the presence of unvaccinated people will remain important.

      However, the vaccine is not yet available in Brazil, which is so far using two others: Chinese-developed CoronaVac and one developed by Oxford University and British-Swedish pharmaceutical firm AstraZeneca.

      Phil Dormitzer, one of Pfizer's top viral vaccine scientists, said in an interview that he believes the current vaccine - developed with Germany's BioNTech SE - is highly likely to still protect against the concerning variant first discovered in South Africa.

      Planning Minister Asad Umar, who is also chief of the anti-corona National Command and Operation Center (NCOC), said that the vaccination of the registered elderly people would begin next month.

      The coronavirus vaccine — one of the world’s most in-demand commodities — has become a new currency for international diplomacy. Countries with the means or the know-how are using the shots to curry favor or thaw frosty relations. India sent them to Nepal, a country that has fallen increasingly under China’s influence. Sri Lanka, in the midst of a diplomatic tug of war between New Delhi and Beijing, is getting doses from both.

    Load More...
    The Economic Times